World's Best Scientists 2026 revealed!
Ronald M. Laxer

Ronald M. Laxer

D-Index & Metrics

Medicine

D-Index
86
Citations
25274
World Ranking
14209
National Ranking
589

Overview

Ronald M. Laxer is affiliated with the University of Toronto in Canada. Their research contributions span the field of Medicine with a strong emphasis on Surgery, Hematology, and Rheumatology, along with notable work in Molecular Biology and Speech and Hearing.

The scientist's research focuses on several key topics including autoimmune and inflammatory disorders, adolescent and pediatric healthcare, inflammasome and immune disorders, Kawasaki disease and coronary complications, osteomyelitis and bone disorders, infectious diseases and tuberculosis, as well as orthopedic infections and treatments.

Frequent co-authors in their work include Tala El Tal, Roberta Berard, Rae S. M. Yeung, Susanne M. Benseler, and Elena Pope, with multiple joint publications reflecting ongoing collaborative efforts.

They have published extensively in various respected venues, with a significant number of articles appearing in:

  • The Journal of Rheumatology
  • Arthritis & Rheumatology
  • Pediatric Rheumatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Lara D. Veeken

Representative recent papers include:

  • The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist, 2022, Annals of the Rheumatic Diseases
  • Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice, 2021, Nature Genetics
  • A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction, 2020, Nature Communications
  • The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial, 2020, Lara D. Veeken
  • American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1, 2020, Arthritis & Rheumatology

Best Publications

  • An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

    Ivona Aksentijevich;Seth L. Masters;Polly J. Ferguson;Paul Dancey

  • 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features

    Timothy Beukelman;Nivedita M. Patkar;Kenneth G. Saag;Sue Tolleson-Rinehart

  • An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

    Scott W. Canna;Adriana Almeida de Jesus;Sushanth Gouni;Stephen R. Brooks

  • Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

    Qing Zhou;Hongying Wang;Daniella M. Schwartz;Monique Stoffels

  • Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.

    Anath C Lionel;Gregory Costain;Nasim Monfared;Susan Walker

  • Classification criteria for autoinflammatory recurrent fevers

    Marco Gattorno;Michael Hofer;Silvia Federici;Federica Vanoni

  • Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study

    F. Zulian;B. H. Athreya;R. Laxer;A. M. Nelson

  • Medical Treatment of Juvenile Idiopathic Arthritis

    Philip J. Hashkes;Ronald M. Laxer

  • Toward New Classification Criteria for Juvenile Idiopathic Arthritis : First Steps, Pediatric Rheumatology International Trials Organization International Consensus

    Alberto Martini;Angelo Ravelli;Tadej Avcin;Michael W. Beresford

  • Localized scleroderma in childhood is not just a skin disease.

    Francesco Zulian;Cristina Vallongo;Patricia Woo;Ricardo Russo

  • 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications

    Sarah Ringold;Pamela F. Weiss;Timothy Beukelman;Esi Morgan DeWitt

  • CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome.

    Jose Marcelino;John D. Carpten;Wafaa M. Suwairi;Orlando M. Gutierrez

  • Treating juvenile idiopathic arthritis to target: recommendations of an international task force

    Angelo Ravelli;Alessandro Consolaro;Gerd Horneff;Ronald M Laxer

  • Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up.

    Adam M. Huber;Pei-Yoong Lam;Catherine M. Duffy;Rae S.M. Yeung

  • Epidemiology of Juvenile Idiopathic Arthritis in a Multiethnic Cohort Ethnicity as a Risk Factor

    R. K. Saurenmann;J. B. Rose;P. Tyrrell;B. M. Feldman

  • Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study

    R. K. Saurenmann;A. V. Levin;B. M. Feldman;J. B. Rose

  • The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

    Jaime Guzman;Kiem Oen;Lori B Tucker;Adam M Huber

  • Tumour necrosis factor α inhibitors in the treatment of childhood uveitis

    R. K. Saurenmann;A. V. Levin;J. B. Rose;S. Parker

  • Methotrexate and corticosteroid therapy for pediatric localized scleroderma

    Yosef Uziel;Brian M. Feldman;Bernice R. Krafchik;Rae S.M. Yeung

  • The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis†‡

    Francesco Zulian;Patricia Woo;Balu H. Athreya;Ronald M. Laxer

Frequent Co-Authors

Earl D. Silverman
Earl D. Silverman University of Toronto
Brian M. Feldman
Brian M. Feldman University of Toronto
Daniel J. Lovell
Daniel J. Lovell Cincinnati Children's Hospital Medical Center
Seza Ozen
Seza Ozen Hacettepe University
Stuart E. Turvey
Stuart E. Turvey University of British Columbia
Marco Gattorno
Marco Gattorno Istituto Giannina Gaslini
Gideon Koren
Gideon Koren Brown University
Elie Haddad
Elie Haddad University of Montreal
Robert D. Inman
Robert D. Inman University of Toronto
Ivona Aksentijevich
Ivona Aksentijevich National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine goes beyond traditional medical school. Today, many find fulfilling and in-demand pathways through related healthcare programs available online. For those interested in the administrative side, earning a degree in healthcare administration can open doors to leadership roles without direct patient care.

If you’re looking for clinical opportunities, there are schools that offer nursing school that does not require teas test, making the entry process smoother for aspiring nurses. For registered nurses aiming to advance their careers, specialized bridge programs like rn to fnp bridge programs can help them become Family Nurse Practitioners through an accelerated route.

In the rapidly-growing field of medical billing, you may wonder, can you get financial aid for medical billing and coding? Many accredited programs offer options that make this career path more accessible.

Whether you’re drawn to clinical or administrative roles, these online degrees and career tracks provide flexible, accessible ways to enter or advance in the healthcare industry.

Best Scientists Citing Ronald M. Laxer

Trending Scientists

Recently Published Articles